ConquerX is developing the next-generation medical device for molecular diagnostics, the Metachip. ConquerX's Metachip technology represents a game-changing approach to cancer diagnostics and screening by leveraging a new class of biomarkers - microRNAs - to earlier detect up to eighteen types of cancer in one simple, accurate, cost-effective blood test.
View Top Employees from ConquerX| Website | http://www.conquerxlab.com |
| Revenue | $5 million |
| Employees | 5 (0 on RocketReach) |
| Founded | 2016 |
| Address | 100 Morrissey Blvd, Boston, Massachusetts 02125, US |
| Phone | (617) 287-6070 |
| Technologies |
JavaScript,
HTML,
Nginx
+1 more
(view full list)
|
| Industry | Biotechnology, Medical Testing & Clinical Laboratories, Healthcare, Science and Engineering, Life Science, Medical, Health Care, Medical Device |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies, SIC Code 8071 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular ConquerX employee's phone or email?
ConquerX Questions
The ConquerX annual revenue was $5 million in 2024.
ConquerX is based in Boston, Massachusetts.
The NAICS codes for ConquerX are [621, 62].
The SIC codes for ConquerX are [80, 807, 8071].
Related Companies
